• Efficient Synthesis of Deuterium-Labeled Degarelix Acetate

  2026-07-17

  This study establishes a multi-step, high-yield method for synthesizing deuterium-labeled degarelix acetate, a crucial internal standard for pharmacokinetic and metabolism studies in androgen-related diseases. The approach leverages D2O/D3PO4 for site-selective deuteration and solid-phase peptide synthesis, offering improved reproducibility and standardization for clinical research.

• Systematic In Vitro Profiling of Leucomycin's Antibacterial

  2026-07-16

  This classic study by Iwata and Akiba delivers a systematic evaluation of leucomycin (kitasamycin) and its fractions against a broad panel of pathogenic and resistant bacteria. Through rigorous comparative methods, it establishes foundational data on leucomycin's spectrum, stability, and potential in translational inhibition studies.

• Cell-to-Cell Transmission of Immunoproteasomes via Extracell

  2026-07-16

  This study uncovers direct cell-to-cell transfer of non-constitutive proteasomes—specifically immunoproteasomes—through extracellular vesicles (EVs). These findings suggest new dimensions for immune regulation and may inform future strategies for targeted immunoproteasome inhibition in disease models.

• Validating BCS Biowaiver for Taltirelin ODTs: Dissolution an

  2026-07-15

  This study experimentally validates the use of the biopharmaceutical classification system (BCS) biowaiver for assessing bioequivalence between orally disintegrating tablets (ODTs) and immediate release (IR) formulations of Taltirelin, a BCS class III compound. Its findings streamline regulatory approval for generic formulations and inform optimal dissolution criteria for neuroactive agents.

• Protease Inhibitor Cocktail EDTA-Free: Precision in Protein

  2026-07-15

  The Protease Inhibitor Cocktail (EDTA-Free, 100X in DMSO) empowers sensitive protein extraction workflows by ensuring robust inhibition of serine, cysteine, and acid proteases without interfering with phosphorylation analysis. Streamline your experimental design and safeguard labile protein modifications with this APExBIO solution tailored for advanced molecular biology.

• Molecular Epidemiology and Resistance of Candidozyma auris i

  2026-07-14

  This study delivers a comprehensive molecular and phenotypic analysis of Candidozyma auris isolates from South China, revealing clade-specific antifungal resistance and virulence traits. The findings expand local genetic surveillance and inform targeted infection control strategies.

• Viral Inducers of RIPK3 Degradation Shape Necroptosis and In

  2026-07-14

  Liu et al. (2021) identify a novel class of viral proteins that target the necroptosis adaptor RIPK3 for ubiquitin-mediated degradation, thereby suppressing necroptotic cell death and modulating virus-induced inflammation. This discovery reveals new mechanisms of host-pathogen interaction and suggests directions for dissecting ubiquitin-dependent immune evasion.

• Overcoming Drug Resistance: Lipid Transfection Reagents in T

  2026-07-13

  This article explores the mechanistic foundations and strategic applications of advanced lipid transfection reagents—focusing on Lipo3K Transfection Reagent—for translational researchers tackling multidrug resistance and gene modulation in challenging cell models. We bridge recent mechanistic insights on membrane cholesterol and transporter biology with actionable guidance for gene delivery, co-transfection, and workflow optimization in the context of cutting-edge cancer research.

• Cyclo (-RGDfC): Applied Workflows in Tumor Targeting Peptide

  2026-07-13

  Cyclo (-RGDfC) empowers precision targeting of integrin αvβ3 in cancer and angiogenesis studies. This article details optimized experimental workflows, advanced applications, and troubleshooting tips for leveraging this cyclic peptide in integrin-mediated cell adhesion, drug delivery, and high-throughput biomaterial assays.

• CX-4945 (Silmitasertib): Applied CK2 Inhibition in Cancer &

  2026-07-12

  CX-4945 (Silmitasertib) delivers robust, reproducible CK2 inhibition for both cancer and viral research, uniquely bridging oncology and infectious disease. This guide distills experimental workflows, troubleshooting strategies, and new cross-domain insights to help scientists unlock precise, high-impact results with APExBIO’s trusted CK2 inhibitor.

• Plk1-Mediated Regulation of p31comet in Mitotic Checkpoint D

  2026-07-10

  This study uncovers how Polo-like kinase 1 (Plk1) directly modulates the activity of p31comet, a key factor in mitotic checkpoint complex (MCC) disassembly, via site-specific phosphorylation. These findings clarify a previously ambiguous regulatory mechanism that ensures fidelity during mitosis and highlights new considerations for cell cycle intervention strategies.

• Triptolide (PG490): Unveiling Transcriptional Control in Can

  2026-07-09

  Explore how Triptolide (PG490) uniquely disrupts gene activation and pluripotency networks, with mechanistic depth linking cancer research and stem cell biology. Discover advanced assay guidance and practical insights beyond standard IL-2/NF-κB inhibition.

• Translating ddhCTP Mechanisms into Antiviral Innovation

  2026-07-09

  This thought-leadership article explores how ddhCTP (3ʹ-deoxy-3′,4ʹ-didehydro-CTP), a unique antiviral nucleotide analog produced by viperin, is redefining antiviral strategies. By connecting mechanistic insight with translational guidance, we show how APExBIO’s high-purity ddhCTP empowers researchers to interrogate RNA virus replication, design next-generation inhibitors, and navigate emerging viral threats. We synthesize recent evidence on viperin’s dual antiviral modes with real-world experimental workflows, address the evolving competitive landscape, and outline a forward-looking strategy for translational virology.

• Cell Divisions Refine Tissue Boundaries in Drosophila Embryo

  2026-07-08

  This study reveals that cell divisions at tissue boundaries in Drosophila embryos not only challenge but also refine these interfaces by modulating mechanical tension and tissue fluidity. The findings advance understanding of how dynamic cellular behaviors contribute to tissue organization, with implications for developmental biology and cancer research.

• TMEM16F Lipid Scrambling Modulates Ferroptosis and Tumor Imm

  2026-07-08

  Yang et al. identify TMEM16F-mediated lipid scrambling as a key suppressor at the executional phase of ferroptosis, revealing that its inhibition not only sensitizes cells to ferroptotic death but also enhances tumor immune rejection. These findings clarify late-stage plasma membrane remodeling events in ferroptosis and suggest new therapeutic strategies involving redox modulation and immune checkpoint blockade.

450 records 11/30 page Previous Next First page 上5页 1112131415 下5页 Last page